NCT00704145View on ClinicalTrials.gov

Optical Coherence Tomography Following Paclitaxel Eluting Stent Implantation in Multivessel Coronary Artery Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

November 30, 2009

Conditions
Coronary Artery Disease
Interventions
DEVICE

Taxus Libertè™ paclitaxel drug-eluting stent

device:Taxus Libertè™ (Boston Scientific,Natick,MS)assessed at different time points after implant

Trial Locations (1)

24100

Ospedali Riuniti di Bergamo, Bergamo

Sponsors
All Listed Sponsors
collaborator

Case Western Reserve University

OTHER

collaborator

Boston Scientific Corporation

INDUSTRY

lead

A.O. Ospedale Papa Giovanni XXIII

OTHER

NCT00704145 - Optical Coherence Tomography Following Paclitaxel Eluting Stent Implantation in Multivessel Coronary Artery Disease | Biotech Hunter | Biotech Hunter